Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Conclusion Beyond their established role as potent antihyperglycemic agents, GLP-1RAs show potential for treating neurodegenerative diseases with disease-modifying effects
In mouse microglia, a GLP-1 receptor agonist called NLY01 blocked nuclear translocation of NF-kB entirely when cells were stimulated with bacterial endotoxin
The pharmaceutical industry's evolution in obesity therapeutics has progressed from single-target approaches (pure GLP-1 agonists like semaglutide) to dual agonists (GLP-1/GIP like tirzepatide), and now to triple agonists like retatrutide that attempt to orchestrate an even more comprehensive metabolic remodeling by simultaneously modulating multiple complementary pathways
The receptor is a class B G-protein-coupled receptor that signals mainly through cyclic AMP, and it is expressed far beyond the pancreas, in the brain, gut, vasculature, heart, and kidney
Our Recommended Protocol for Storage and Handling Over the years, our team has refined a set of best practices that we share with the researchers we partner with
